Literature DB >> 16296787

The MediChew technology platform.

Birgitte Hyrup1, Carsten Andersen, Lars Vibe Andreasen, Bo Tandrup, Torben Christensen.   

Abstract

A few decades ago, chewing gum was rarely considered when industry searched for an applicable delivery vehicle for an active pharmaceutical substance. Yet, the 1980s and 1990s saw gum become the most successful nicotine delivery form; unawareness changed to cautious scepticism, and today the merits of chewing gum drug delivery technologies are generally appreciated. MediChew is the registered trademark of Fertin Pharma's medical chewing gum technology platform. Based on patent-protected technologies, it offers unique taste-masking possibilities and allows control of drug molecule release. Medical chewing gum products based on these technologies are specifically suitable for convenient administration on demand, for active substances providing a topical effect in the oral cavity and throat, and for systemic delivery of drug molecules that readily cross the oromucosal membranes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16296787     DOI: 10.1517/17425247.2.5.927

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  2 in total

Review 1.  Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.

Authors:  Felipe L Lopez; Terry B Ernest; Catherine Tuleu; Mine Orlu Gul
Journal:  Expert Opin Drug Deliv       Date:  2015-07-13       Impact factor: 6.648

2.  Medicated Chewing Gums: Recent Patents and Patented Technology Platforms.

Authors:  Prerna Kaushik; Deepak Kaushik
Journal:  Recent Pat Drug Deliv Formul       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.